108 BioCapital领投 SedMed， Inc.融资，投资额达 400万美元-动脉网

108 BioCapital Leads SedMed, Inc. Financing with $4 Million Investment

CISION 等信源发布 2026-10-02 00:00



可切换为仅中文







DANBURY, Conn.

康涅狄格州丹伯里

，

Oct. 1, 2026

2026年10月1日

/PRNewswire/ -- 108 BioCapital today announced that it is leading a financing round in SedMed, Inc. with a $4 million investment. The financing will support SedMed's next phase of commercial growth and expand access to its non-electric toilet lift, which is designed to help older adults and individuals with mobility limitations sit and stand more safely and independently while reducing strain on caregivers..

/美通社/ -- 108 BioCapital 今日宣布，领投SedMed, Inc.的融资轮次，投资金额为400万美元。该笔融资将支持SedMed下一阶段的商业增长，并扩大其非电动马桶升降机的可及性。该产品旨在帮助老年人和行动不便者更安全、更独立地完成坐立动作，同时减轻照护人员的负担。

SedMed is a medical device company developing non-electric mobility solutions that help older adults and individuals with limited mobility sit and stand more safely and independently while reducing physical strain on caregivers. Its flagship product, the SedMed Toilet Lift, attaches to most standard toilets and provides adjustable sit-to-stand assistance without electricity, batteries or bathroom remodeling..

SedMed 是一家医疗设备公司，致力于开发非电动移动解决方案，帮助老年人和行动不便者更安全、更独立地完成坐立和站立动作，同时减轻照护人员的身体负担。其旗舰产品 SedMed 马桶升降器可安装在大多数标准马桶上，无需电力、电池或改造卫生间，即可提供可调节的坐站辅助功能。

'SedMed is addressing an important and often overlooked challenge for older adults, individuals with limited mobility and their caregivers,' said Sasha Bakhru, Managing Partner of 108 BioCapital. 'The company has developed an intuitive, non-electric solution with the potential to improve safety, preserve independence and reduce caregiver burden across home and healthcare settings.

“SedMed 正在应对老年人、行动不便者及其照护者所面临的一项重要却常被忽视的挑战，”108 BioCapital 的管理合伙人 Sasha Bakhru 表示。“该公司开发了一种直观的非电动解决方案，有望在家庭和医疗护理场景中提升安全性、维护独立性并减轻照护者的负担。”

We have been impressed by Jeremy and the SedMed team's thoughtful approach to product development and commercialization, and we are pleased to lead this investment and support the company's next phase of growth.'.

我们对Jeremy和SedMed团队在产品开发与商业化方面所展现的深思熟虑的方法印象深刻，并很高兴能领投此次投资，支持公司进入下一阶段的成长。

SedMed will use the investment to accelerate commercial expansion, grow its distribution and channel partnerships, advance its intellectual property portfolio and conduct additional hospital-based studies.

SedMed 将利用这笔投资加速商业扩张，扩大分销和渠道合作伙伴关系，推进其知识产权组合，并开展更多基于医院的研究。

'SedMed's adoption across more than 40 hospital systems demonstrates strong demand for its solution and validates the important role it can play in addressing a significant challenge for healthcare providers,' said Shahryar Oveissi, General Partner of 108 BioCapital. 'That momentum also sets the stage for SedMed to become a trusted solution for older adults living at home, where physical limitations, cognitive decline and environmental barriers can increase the risk of accidents and place added strain on caregivers.'.

“SedMed 在超过 40 家医院系统中的广泛应用，彰显了市场对其解决方案的强劲需求，并验证了其在应对医疗服务提供者所面临的一项重大挑战方面所能发挥的重要作用。”108 BioCapital 的普通合伙人 Shahryar Oveissi 表示。“这一发展势头也为 SedMed 成为居家老年人值得信赖的解决方案奠定了基础。对于居家老年人而言，身体机能受限、认知能力下降以及环境障碍可能会增加意外事故的风险，并给照护者带来额外负担。”

'SedMed's practical, non-electric design gives the product meaningful potential beyond the United States,' said Shom Jagtiani, General Partner of 108 BioCapital. 'We see particular opportunity in India and other international markets, where an easy-to-deploy solution could help improve bathroom safety and independence for older adults across home and healthcare settings.'.

“SedMed 实用且无需电力的设计，使该产品在美国以外市场拥有巨大的潜力。”108 BioCapital 的普通合伙人 Shom Jagtiani 表示。“我们认为，在印度及其他国际市场存在特别的机遇，在这些市场中，易于部署的解决方案有助于提升老年人在家庭及医疗护理环境中的浴室安全性和独立性。”

'This investment represents an important milestone for SedMed as we work to make safer bathroom mobility accessible to more people,' said Jeremy Bronen, CEO of SedMed. '108 BioCapital brings healthcare expertise and a shared commitment to supporting technologies that can meaningfully improve the lives of patients and caregivers.

SedMed首席执行官杰里米·布罗宁表示：“随着我们致力于让更多人都能享受到更安全的浴室移动辅助，这笔投资对SedMed而言是一个重要的里程碑。108 BioCapital带来了医疗保健领域的专业知识，以及对我们共同支持能够切实改善患者和照护者生活的技术的承诺。”

This funding will allow us to expand our commercial reach, strengthen our distribution network and build additional evidence demonstrating the value SedMed can provide to healthcare organizations.'.

这笔资金将使我们能够扩大商业覆盖范围，加强分销网络，并积累更多证据，以证明 SedMed 能够为医疗健康组织提供的价值。

About SedMed, Inc.

关于 SedMed 公司

SedMed, Inc. is a Milford, CT based medical device company developing reliable, non-electric mobility solutions that support bathroom safety, independence and dignity for older adults and individuals with limited mobility while reducing strain on caregivers. Its flagship SedMed Toilet Lift provides adjustable assistance for sitting and standing and is designed for use in homes, senior living communities and healthcare settings.

SedMed, Inc. 是一家总部位于康涅狄格州米尔福德的医疗器械公司，致力于开发可靠、非电动的移动辅助解决方案，在减轻照护者负担的同时，为老年人及行动不便人士提供如厕安全、独立性与尊严保障。其旗舰产品 SedMed 马桶升降器可为坐立和站立提供可调节的辅助支持，适用于家庭、养老社区及医疗保健场所。

For more information, visit .

更多信息，请访问。

https://sed-med.com/

。

About 108 BioCapital

关于108 BioCapital

108 BioCapital is a U.S.-based private equity firm focused on growth-stage investments in biotech and medtech companies developing scalable, exit-driven solutions that address high-impact unmet medical needs. The firm also maintains a feeder vehicle in GIFT City, India. For more information, visit

108 BioCapital 是一家总部位于美国的私募股权公司，专注于对生物技术和医疗技术企业进行成长期投资，这些企业致力于开发可扩展、以退出为导向的解决方案，以应对具有高影响力的未满足医疗需求。该公司还在印度吉夫特城（GIFT City）设有一只 feeder 基金。欲了解更多信息，请访问

108.bio

。

Media Contacts

媒体联系人

108 BioCapital

Steve Ward

史蒂夫·沃德

Chief Financial Officer

首席财务官

[email protected]

SedMed, Inc.